AAAAAA

   
Results: 1-19 |
Results: 19
CANCER-ASSOCIATED MUC1 MUCIN INHIBITS HUMAN T-CELL PROLIFERATION, WHICH IS REVERSIBLE BY IL-2
Authors: AGRAWAL B KRANTZ MJ REDDISH MA LONGENECKER BM
Citation: B. Agrawal et al., CANCER-ASSOCIATED MUC1 MUCIN INHIBITS HUMAN T-CELL PROLIFERATION, WHICH IS REVERSIBLE BY IL-2, Nature medicine, 4(1), 1998, pp. 43-49
LIPOSOMAL FORMULATIONS OF SYNTHETIC MUC1 PEPTIDES - EFFECTS OF ENCAPSULATION VERSUS SURFACE DISPLAY OF PEPTIDES ON IMMUNE-RESPONSES
Authors: GUAN HH BUDZYNSKI W KOGANTY RR KRANTZ MJ REDDISH MA ROGERS JA LONGENECKER BM SAMUEL J
Citation: Hh. Guan et al., LIPOSOMAL FORMULATIONS OF SYNTHETIC MUC1 PEPTIDES - EFFECTS OF ENCAPSULATION VERSUS SURFACE DISPLAY OF PEPTIDES ON IMMUNE-RESPONSES, Bioconjugate chemistry, 9(4), 1998, pp. 451-458
ANALYSIS OF THE ROLE OF TYPE-1 CORE O-GLYCANS IN THE BINDING OF ANTI-MUC1 ANTIBODIES BY CYTOFLUOROMETRY AND SYNTHETIC PEPTIDE GLYCOPEPTIDE BINDING-INHIBITION STUDIES/
Authors: REDDISH MA SURESH MR KOGANTY RR FORTIER S BARONIC L BERG A MICHAEL B LONGENECKER BM
Citation: Ma. Reddish et al., ANALYSIS OF THE ROLE OF TYPE-1 CORE O-GLYCANS IN THE BINDING OF ANTI-MUC1 ANTIBODIES BY CYTOFLUOROMETRY AND SYNTHETIC PEPTIDE GLYCOPEPTIDE BINDING-INHIBITION STUDIES/, Tumor biology, 19, 1998, pp. 57-66
ANTI-MUC1 CLASS-I RESTRICTED CTLS IN METASTATIC BREAST-CANCER PATIENTS IMMUNIZED WITH A SYNTHETIC MUC1 PEPTIDE
Authors: REDDISH MA MACLEAN GD KOGANTY RR KANMITCHELL J JONES V MITCHELL MS LONGENECKER BM
Citation: Ma. Reddish et al., ANTI-MUC1 CLASS-I RESTRICTED CTLS IN METASTATIC BREAST-CANCER PATIENTS IMMUNIZED WITH A SYNTHETIC MUC1 PEPTIDE, International journal of cancer, 76(6), 1998, pp. 817-823
IMMUNOGENICITY AND ANTITUMOR-ACTIVITY OF A LIPOSOMAL MUC1 PEPTIDE-BASED VACCINE
Authors: SAMUEL J BUDZYNSKI WA REDDISH MA DING L ZIMMERMANN GL KRANTZ MJ KOGANTY RR LONGENECKER BM
Citation: J. Samuel et al., IMMUNOGENICITY AND ANTITUMOR-ACTIVITY OF A LIPOSOMAL MUC1 PEPTIDE-BASED VACCINE, International journal of cancer, 75(2), 1998, pp. 295-302
THE ANTI-MUC1 MONOCLONAL-ANTIBODY BCP8 CAN BE USED TO ISOLATE AND IDENTIFY PUTATIVE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ASSOCIATED AMINO-ACID-SEQUENCES
Authors: AGRAWAL B REDDISH MA CHRISTIAN B VANHEELE A TANG L KOGANTY RR LONGENECKER BM
Citation: B. Agrawal et al., THE ANTI-MUC1 MONOCLONAL-ANTIBODY BCP8 CAN BE USED TO ISOLATE AND IDENTIFY PUTATIVE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ASSOCIATED AMINO-ACID-SEQUENCES, Cancer research, 58(22), 1998, pp. 5151-5156
PROGNOSTIC-SIGNIFICANCE OF PREIMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AFTER ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC ADENOCARCINOMA PATIENTS
Authors: MACLEAN GD REDDISH MA LONGENECKER BM
Citation: Gd. Maclean et al., PROGNOSTIC-SIGNIFICANCE OF PREIMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AFTER ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC ADENOCARCINOMA PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 70-78
SPECIFICITIES OF ANTI-SIALYL-TN AND ANTI-TN MONOCLONAL-ANTIBODIES GENERATED USING NOVEL CLUSTERED SYNTHETIC GLYCOPEPTIDE EPITOPES
Authors: REDDISH MA JACKSON L KOGANTY RR QIU DX HONG W LONGENECKER BM
Citation: Ma. Reddish et al., SPECIFICITIES OF ANTI-SIALYL-TN AND ANTI-TN MONOCLONAL-ANTIBODIES GENERATED USING NOVEL CLUSTERED SYNTHETIC GLYCOPEPTIDE EPITOPES, Glycoconjugate journal, 14(5), 1997, pp. 549-560
GLYCOPEPTIDE-BASED AND CARBOHYDRATE-BASED SYNTHETIC VACCINES FOR THE IMMUNOTHERAPY OF CANCER
Authors: KOGANTY RR REDDISH MA LONGENECKER BM
Citation: Rr. Koganty et al., GLYCOPEPTIDE-BASED AND CARBOHYDRATE-BASED SYNTHETIC VACCINES FOR THE IMMUNOTHERAPY OF CANCER, Drug discovery today, 1(5), 1996, pp. 190-198
ENHANCING THE EFFECT OF THERATOPE STN-KLH CANCER VACCINE IN PATIENTS WITH METASTATIC BREAST-CANCER BY PRETREATMENT WITH LOW-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE
Authors: MACLEAN GD MILES DW RUBENS RD REDDISH MA LONGENECKER BM
Citation: Gd. Maclean et al., ENHANCING THE EFFECT OF THERATOPE STN-KLH CANCER VACCINE IN PATIENTS WITH METASTATIC BREAST-CANCER BY PRETREATMENT WITH LOW-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 309-316
ANTIBODIES AGAINST MUCIN-ASSOCIATED SIALYL-TN EPITOPES CORRELATE WITHSURVIVAL OF METASTATIC ADENOCARCINOMA PATIENTS UNDERGOING ACTIVE SPECIFIC IMMUNOTHERAPY WITH SYNTHETIC STN VACCINE
Authors: MACLEAN GD REDDISH MA KOGANTY RR LONGENECKER BM
Citation: Gd. Maclean et al., ANTIBODIES AGAINST MUCIN-ASSOCIATED SIALYL-TN EPITOPES CORRELATE WITHSURVIVAL OF METASTATIC ADENOCARCINOMA PATIENTS UNDERGOING ACTIVE SPECIFIC IMMUNOTHERAPY WITH SYNTHETIC STN VACCINE, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 59-68
PRE-IMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AND CD69(-TN-KLH CANCER VACCINE IN ACTIVE SPECIFIC IMMUNOTHERAPY() LYMPHOCYTES CORRELATE WITH EFFECTS OF THERATOPE(R) SIALYL)
Authors: REDDISH MA MACLEAN GD POPPEMA S BERG A LONGENECKER BM
Citation: Ma. Reddish et al., PRE-IMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AND CD69(-TN-KLH CANCER VACCINE IN ACTIVE SPECIFIC IMMUNOTHERAPY() LYMPHOCYTES CORRELATE WITH EFFECTS OF THERATOPE(R) SIALYL), Cancer immunology and immunotherapy, 42(5), 1996, pp. 303-309
IN-VITRO INDUCTION OF MUC-1 PEPTIDE-SPECIFIC TYPE-1 T-LYMPHOCYTE AND CYTOTOXIC T-LYMPHOCYTE RESPONSES FROM HEALTHY MULTIPAROUS DONORS
Authors: AGRAWAL B REDDISH MA LONGENECKER BM
Citation: B. Agrawal et al., IN-VITRO INDUCTION OF MUC-1 PEPTIDE-SPECIFIC TYPE-1 T-LYMPHOCYTE AND CYTOTOXIC T-LYMPHOCYTE RESPONSES FROM HEALTHY MULTIPAROUS DONORS, The Journal of immunology, 157(5), 1996, pp. 2089-2095
THE BREAST MUCIN MUC1 AS A NOVEL ADHESION LIGAND FOR ENDOTHELIAL INTERCELLULAR-ADHESION MOLECULE-1 IN BREAST-CANCER
Authors: REGIMBALD LH PILARSKI LM LONGENECKER BM REDDISH MA ZIMMERMANN G HUGH JC
Citation: Lh. Regimbald et al., THE BREAST MUCIN MUC1 AS A NOVEL ADHESION LIGAND FOR ENDOTHELIAL INTERCELLULAR-ADHESION MOLECULE-1 IN BREAST-CANCER, Cancer research, 56(18), 1996, pp. 4244-4249
ACTIVE SPECIFIC IMMUNOTHERAPY OF ADENOCARCINOMAS WITH SYNTHETIC TUMOR-ASSOCIATED ANTIGENS CONJUGATED TO KEYHOLE LIMPET HEMOCYANIN
Authors: REDDISH MA BUSZYNSKI V DING L LONGENECKER BM
Citation: Ma. Reddish et al., ACTIVE SPECIFIC IMMUNOTHERAPY OF ADENOCARCINOMAS WITH SYNTHETIC TUMOR-ASSOCIATED ANTIGENS CONJUGATED TO KEYHOLE LIMPET HEMOCYANIN, Onkologie, 18, 1995, pp. 33-35
STRUCTURALLY DEFINED SYNTHETIC CANCER VACCINES - ANALYSIS OF STRUCTURE, GLYCOSYLATION AND RECOGNITION OF CANCER-ASSOCIATED MUCIN, MUC-1 DERIVED PEPTIDES
Authors: LIU XH SEJBAL J KOTOVYCH G KOGANTY RR REDDISH MA JACKSON L GANDHI SS MENDONCA AJ LONGENECKER BM
Citation: Xh. Liu et al., STRUCTURALLY DEFINED SYNTHETIC CANCER VACCINES - ANALYSIS OF STRUCTURE, GLYCOSYLATION AND RECOGNITION OF CANCER-ASSOCIATED MUCIN, MUC-1 DERIVED PEPTIDES, Glycoconjugate journal, 12(5), 1995, pp. 607-617
CD69(-DR(+) ACTIVATION ANTIGENS ON PERIPHERAL-BLOOD LYMPHOCYTE POPULATIONS IN METASTATIC BREAST AND OVARIAN-CANCER PATIENTS - CORRELATIONS WITH SURVIVAL FOLLOWING ACTIVE SPECIFIC IMMUNOTHERAPY() AND HLA)
Authors: YACYSHYN MBB POPPEMA S BERG A MACLEAN GD REDDISH MA MEIKLE A LONGENECKER BM
Citation: Mbb. Yacyshyn et al., CD69(-DR(+) ACTIVATION ANTIGENS ON PERIPHERAL-BLOOD LYMPHOCYTE POPULATIONS IN METASTATIC BREAST AND OVARIAN-CANCER PATIENTS - CORRELATIONS WITH SURVIVAL FOLLOWING ACTIVE SPECIFIC IMMUNOTHERAPY() AND HLA), International journal of cancer, 61(4), 1995, pp. 470-474
DOES PREGNANCY IMMUNIZE AGAINST BREAST-CANCER
Authors: AGRAWAL B REDDISH MA KRANTZ MJ LONGENECKER BM
Citation: B. Agrawal et al., DOES PREGNANCY IMMUNIZE AGAINST BREAST-CANCER, Cancer research, 55(11), 1995, pp. 2257-2261
ACTIVE SPECIFIC IMMUNOTHERAPY AGAINST ADENOCARCINOMAS
Authors: MACLEAN GD REDDISH MA BOWENYACYSHYN MB POPPEMA S LONGENECKER BM
Citation: Gd. Maclean et al., ACTIVE SPECIFIC IMMUNOTHERAPY AGAINST ADENOCARCINOMAS, Cancer investigation, 12(1), 1994, pp. 46-56
Risultati: 1-19 |